News Search & Analytics
US Edition
Minimum 3 characters required!!

BRIEF-Allergan enters parkinson's disease through option arrangement with Lysosomal Therapeutics

Mon Jan 09 04:40:34 EST 2017 | Reuters
Jan 9 Allergan Plc : * Allergan enters parkinson's disease through option arrangement with Lysosomal Therapeutics Inc (LTI) for its potential first-in-class breakthrough compounds * Allergan Plc - additional terms were not disclosed. * Allergan Plc - purchased an option right directly from LTI shareholders to acquire LTI following completion of a phase 1b trial for LTI-291 * Allergan Plc - option to acquire LTI following completion of phase 1B clinical trial * Allergan Plc - Allergan will provid..

Advertisement


Today Allergan announced a transformative deal with Lysosomal Therapeutics (LTI), an emerging biotech focused on Parkinson’s Disease through an understanding of human genetics and ..
Jan 9 Allergan Plc : * Allergan enters parkinson's disease through option arrangement with Lysosomal Therapeutics Inc (LTI) for its potential first-in-class breakthrough compounds ..
Jan 11 TG Therapeutics Inc * TG therapeutics announces completion of enrollment and B-cell depletion data from part 1 of ongoing phase 2 multiple sclerosis study * TG Therapeutics ..
Fiat Chrysler Automobiles announced Sunday it would invest $1 billion in plants in Michigan and Ohio, creating 2,000 jobs, but the deal will not be finalized until incentives from ..
Jan 5 Cesca Therapeutics Inc : * Cesca announces FDA approval of IDE supplement for Phase III clinical trial * FDA recognized need to increase available patient population in order..
Jan 5 Ocera Therapeutics Inc : * Ocera Therapeutics Inc - announces successful phase 1 clinical study of orally-administered ocr-002 in patients with cirrhosis * Ocera Therapeutics..
Jan 6 Puma Biotechnology Inc : * Puma Biotechnology expands cohort in phase II summit trial of PB272 in HER2 mutation-positive cancer patients * Puma Biotechnology-cohort that has ..
Allergan Plc (AGN.N), taking a more "realistic" approach to its forecast, said on Thursday it expects mid-single digit net revenue percentage growth this year, helped by key produc..
Jan 11 General Electric Co * Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process developmen..
1 of 132 “Live!” has had 60 different guest co-hosts across 130 episodes since Michael Strahan bailed on Kelly Ripa — here’s how their syndicated ratings have stacked up Kelly Ripa..
This week, we chat about how long dinosaur eggs take—or took—to hatch, a new survey that confirms the world’s hot spots for lightning, and replenishing endangered species with fera..
San Diego’s Otonomy says it will file for expanded marketing permission to sell its ear drug Otiprio to treat acute otitis externa, also known as “swimmer’s ear,” based on a s..
San Diego’s Otonomy says it will file for expanded marketing permission to sell its ear drug Otiprio to treat acute otitis externa, also known as “swimmer’s ear,” based on a s..
It's not easy being a CEO on the hot seat at a conference when your company's stock is down nearly 30% over the last 12 months. Allergan (NYSE: AGN) CEO Brent Saunders experienced ..
Anytime you’re hunkering down at work to wrap up projects on a tight deadline, chances are you’re in full-on multitasking mode. You may think it transforms you into a to-do-list-ta..
In his first press conference since winning the presidency, Donald Trump vehemently denied unverified opposition research reports that he has been compromised by the Russian govern..
Dylann Roof stared forward, displaying no emotion, as more relatives of his victims told stories of lives disrupted by the 2015 massacre at Emanuel AME Church. The prosecution rest..
SpaceX’s upcoming Falcon 9 launch has been postponed, again. The launch, originally scheduled to take place on Jan. 8, had been pushed back to Jan. 9, and on Sunday, it was resched..
Jan 11 Merck Kgaa * Merck KGaA, Darmstadt, Germany, licenses four oncology research and development programs from Vertex and becomes a leader in DNA damage and repair * Merck KGaA,..
U.S. stock futures are bouncing around breakeven heading into the open this morning, as Wall Street weighs its options ahead of today’s December non-farm payrolls report. Yesterday..
The first day back following a firmly bullish week was anything but bullish. With nothing to inspire another round of buying, the S&P 500 drifted 0.35% lower on Monday to a clo..
When Ricardo and Catherine Soto were looking to buy a home in Chula Vista, they knew that even after selling their old house in El Cajon they would be able to afford a down pa..
When Ricardo and Catherine Soto were looking to buy a home in Chula Vista, they knew that even after selling their old house in El Cajon they would be able to afford a down pa..
Updated 48 minutes ago Allegheny Technologies Inc. is blaming an error by a vendor for a delay in pension payments getting to retirees this week. The problem was corrected, and dir..
The S&P 500 and Dow Jones Industrial Average are pushing new highs as we close the first week of trading of 2017. Although the tailwind of the Trump rally has been incredibly s..
I’m Business columnist David Lazarus, and here’s a rundown of upcoming stories this week and the highlights of last week. Trading resumes Monday after the Dow flirted with the hist..
At first glance, Organovo Holdings (NASDAQ: ONVO) versus Akebia Therapeutics (NASDAQ: AKBA) might seem like an apples-and-oranges comparison. Organovo develops 3D bioprinted human ..
Image source: Getty Images. Investors in Aratana Therapeutics(NASDAQ: PETX),a small-cap biotech company focused on developing therapies for pets, had a prosperous 2016. The company..
If you’ve seen Samsung SDI in the news recently, that’s because the Samsung subsidiary was initially fingered as the company that made faulty Galaxy Note 7 batteries that over..
A former Snap Inc. employee said he was wrongfully fired for raising concerns the messaging-app company misled investors with false metrics as it worked toward going public. In a l..
Jan 5 Takeda Pharmaceutical Co Ltd : * Takeda Pharmaceutical Company Limited and PvP Biologics, Inc announced a global agreement for development of Kumamax * Under terms of agreeme..
The week started off poorly for U.S. equities amid a drop in the dollar on Monday. The S&P 500 Index lost 0.4%, and the Dow Jones Industrial Average slipped 0.4%..
A federal judge on Monday ruled that Dylann Roof, the white supremacist found guilty last month of shooting nine parishioners at a Charleston, S.C., Bible study class, is competent..
A 54-year-old woman who attended routine check-ups is urging more awareness of ovarian cancer after she was diagnosed with stage 4 of the disease— five months after doctors said he..
Senate Judiciary Committee Chairman Charles Grassley praised the record of Sen. Jeff Sessions at the start of the Alabama senator’s confirmation hearing Tuesday to be attorney gene..